You have 9 free searches left this month | for more free features.

Epothilones

Showing 1 - 25 of 75

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

CIPN and it's Impact on Quality of Life in Patients Receiving

Not yet recruiting
  • Chemotherapy-induced Peripheral Neuropathy
    • (no location specified)
    Apr 24, 2023

    SCLC, Extensive Stage Trial in Zhengzhou (Utidelone, Placebo)

    Recruiting
    • SCLC, Extensive Stage
    • Zhengzhou, Henan, China
      Henan Tumor Hospital
    Mar 24, 2022

    Bilateral Breast Carcinoma, HER2/Neu Negative, Invasive Breast Carcinoma Trial in Oak Lawn, Houston (Best Practice, Ixabepilone)

    Active, not recruiting
    • Bilateral Breast Carcinoma
    • +2 more
    • Oak Lawn, Illinois
    • +2 more
    Mar 10, 2022

    Chemo Induced Peripheral Neuropathy (CIPN) Trial (Stibium metallicum praeparatum 6x, Placebo)

    Not yet recruiting
    • Chemotherapy Induced Peripheral Neuropathy (CIPN)
    • Stibium metallicum praeparatum 6x
    • Placebo
    • (no location specified)
    Jan 21, 2022

    Solid Tumors Trial in Houston (Patupilone and Omeprazole, Patupilone + Midalzolam)

    Completed
    • Solid Tumors
    • Patupilone and Omeprazole
    • Patupilone + Midalzolam
    • Houston, Texas
      The University of Texas MD Anderson Cancer Center
    Dec 6, 2020

    International CIPN Assessment and Validation Study

    Recruiting
    • Chemotherapy-induced Peripheral Neuropathy
    • Quality of Life
    • outcome measures for CIPN testing
    • Birmingham, Alabama
    • +29 more
    Apr 27, 2022

    Solid Tumors Trial in New York (Iso-Fludelone)

    Active, not recruiting
    • Solid Tumors
    • New York, New York
      Memorial Sloan Kettering Cancer Center
    Jun 7, 2021

    Standard Anti-microtubule Drugs as Assessed by Early Tumor

    Recruiting
    • Breast Cancer
    • Breast Neoplasms
    • Madison, Wisconsin
      University of Wisconsin Carbone Cancer Center
    Dec 10, 2021

    Cervical Carcinoma, Cervical Adenocarcinoma, Cervical Adenosquamous Carcinoma Trial run by the NCI (Ixempra (Ixabepilone

    Terminated
    • Cervical Carcinoma
    • +3 more
    • Ixempra (Ixabepilone (BMS-247550) )
    • Bethesda, Maryland
      National Institutes of Health Clinical Center, 9000 Rockville Pi
    Nov 13, 2019

    Ovarian Cancer, Fallopian Tube Cancer, Peritoneal Tumors Trial in Worldwide (EPO906 (Patupilone), doxorubicin)

    Completed
    • Ovarian Cancer
    • +2 more
    • Anchorage, Alaska
    • +148 more
    Dec 11, 2020

    Medical Oncology Trial in Netherlands, United States (BAY1217389, Paclitaxel)

    Completed
    • Medical Oncology
    • Santa Monica, California
    • +6 more
    Apr 3, 2020

    Non Small Cell Lung Cancer Trial in Italy, United States (Ixabepilone, Cisplatin)

    Completed
    • Non Small Cell Lung Cancer
    • Washington, District of Columbia
    • +6 more
    Oct 6, 2020

    Endometrial Adenocarcinoma, Endometrial Adenosquamous Carcinoma, Endometrial Clear Cell Adenocarcinoma Trial in United States

    Active, not recruiting
    • Endometrial Adenocarcinoma
    • +9 more
    • Bevacizumab
    • +5 more
    • Phoenix, Arizona
    • +232 more
    Jan 12, 2023

    Breast Cancer, Metastases Trial in Worldwide (Ixabepilone + Capecitabine, Capecitabine)

    Completed
    • Breast Cancer
    • Metastases
    • Little Rock, Arkansas
    • +126 more
    Oct 6, 2020

    Cancer, Breast Cancer Trial in Worldwide (Ixabepilone + Capecitabine, Capecitabine)

    Completed
    • Cancer
    • Breast Cancer
    • Tucson, Arizona
    • +188 more
    Oct 6, 2020

    Primary Peritoneal Cavity Cancer, Recurrent Ovarian Epithelial Cancer Trial in Philadelphia (ixabepilone)

    Completed
    • Primary Peritoneal Cavity Cancer
    • Recurrent Ovarian Epithelial Cancer
    • Philadelphia, Pennsylvania
      Gynecologic Oncology Group
    Jul 22, 2019

    Recurrent Uterine Corpus Sarcoma, Uterine Corpus Leiomyosarcoma Trial in United States (Ixabepilone, Laboratory Biomarker

    Completed
    • Recurrent Uterine Corpus Sarcoma
    • Uterine Corpus Leiomyosarcoma
    • Phoenix, Arizona
    • +71 more
    Aug 6, 2019

    Recurrent Uterine Corpus Sarcoma, Uterine Carcinosarcoma Trial in United States (Ixabepilone, Laboratory Biomarker Analysis)

    Completed
    • Recurrent Uterine Corpus Sarcoma
    • Uterine Carcinosarcoma
    • Little Rock, Arkansas
    • +77 more
    Aug 6, 2019

    Breast Cancer, Ovarian Cancer, Solid Tumor Trial in Bronx, New York (BMS-247550)

    Completed
    • Breast Cancer
    • +2 more
    • Bronx, New York
    • +1 more
    Oct 5, 2018

    CNS Tumors, Head and Neck Tumors Trial in Philadelphia (EPO906 (epothilone B))

    Completed
    • Central Nervous System Neoplasms
    • Head and Neck Neoplasms
    • EPO906 (epothilone B)
    • Philadelphia, Pennsylvania
      Thomas Jefferson University Hospital
    Jul 13, 2018

    Medical Oncology Trial in United States (BAY1161909, Paclitaxel)

    Terminated
    • Medical Oncology
    • Santa Monica, California
    • +5 more
    Oct 10, 2018

    Medical Oncology Trial in United Kingdom, United States (BAY1143269 tablet)

    Terminated
    • Medical Oncology
    • BAY1143269 tablet
    • Dallas, Texas
    • +3 more
    Mar 6, 2018

    Prostatic Diseases, Genital Tumors, Male, Urogenital Tumors Trial in Los Angeles (Ixabepilone)

    Terminated
    • Prostatic Diseases
    • +7 more
    • Los Angeles, California
      Cedars-Sinai Medical Center
    Oct 22, 2018

    Adenocarcinoma of the Prostate, Recurrent Prostate Cancer, Stage IV Prostate Cancer Trial in San Francisco, Madison

    Completed
    • Adenocarcinoma of the Prostate
    • +2 more
    • mitoxantrone hydrochloride
    • +2 more
    • San Francisco, California
    • +1 more
    Oct 2, 2017